<DOC>
	<DOCNO>NCT00218374</DOCNO>
	<brief_summary>Individuals reduce stop use opioid medication risk develop hyperalgesia , increased sensitivity pain . This study compare effectiveness dextromethorphan , gabapentin , oxycodone reduce hyperalgesia individual addict opioids concurrently receive methadone treatment .</brief_summary>
	<brief_title>Dextromethorphan , Gabapentin , Oxycodone Treat Opioid-Induced Hyperalgesia</brief_title>
	<detailed_description>Opioid medication frequently use treatment moderate severe pain ; however , individual use opioids high risk become addict . Opioid user abruptly stop use opioid drug may experience withdrawal symptom , include drug craving , sweat , sleep disruption , nausea , irritability , pain . Hyperalgesia , severe excessive sensitivity pain , serious condition may also occur opioid use reduce discontinue . Opioid medication affect pain inhibitory facilitatory system , mean effective treat pain many individual , also ability intensify pain cause hyperalgesia opioid user . Three medication , dextromethorphan , gabapentin , oxycodone , may alleviate symptom hyperalgesia lessen individual 's sensitivity pain . Further research need confirm benefit medication opioid addict . The purpose study compare effectiveness dextromethorphan , gabapentin , oxycodone reduce opioid-induced hyperalgesia methadone-maintained opioid addict . This study involve three separate experiment . Participants Experiment 1 randomly assign receive either dextromethorphan placebo ; Experiment 2 , participant randomly assign receive either gabapentin placebo ; Experiment 3 , participant randomly assign receive either oxycodone placebo . Each experiment last 5 week . All 3 experiment begin screen session . Potential participant undergo physical exam electrocardiogram . Blood urine collect laboratory test drug screening . Each individual 's medical drug history review psychological opiate withdrawal symptom assess . Individuals complete screen meet study requirement permit continue study . All participant maintain methadone throughout study . Participants also receive either study medication ( dextromethorphan , gabapentin , oxycodone ) placebo four time per day begin Day 5 . Study visit take place week . At visit , medication previous week account medication follow week dispense . Questionnaires self-reports complete assess depression level drug use . Urine test use screen presence drug alcohol . During study , participant take part four pain test session measure pain threshold tolerance ; two session take place Week 1 another two session occur Week 5 . The pain testing session include cold pressor ( CP ) test electrical stimulation ( ES ) procedure . The CP test involve place arm ice water short period time ; ES procedure involve stimulate muscle nerve ending via electrode place skin . Immediately CP ES session , blood drawn laboratory test . Participants complete questionnaire self-reports , urine sample collect . Gift card offer incentive attending study visit negative drug test .</detailed_description>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Hyperalgesia</mesh_term>
	<mesh_term>Gabapentin</mesh_term>
	<mesh_term>gamma-Aminobutyric Acid</mesh_term>
	<criteria>Be age 18 55 year age . Meets DSMIV diagnostic criterion opioid dependence Taking stable dose methadone 6 week prior study entry compliant methadone maintenance treatment Is good physical health physician 's care medical condition require ongoing treatment Known sensitivity dextromethorphan , gabapentin , oxycodone Currently dependent alcohol , benzodiazepine , drug ( nicotine ) Currently acutely psychotic , severely depressed state need inpatient treatment Immediate suicide risk Neurological psychiatric illness ( e.g. , peripheral neuropathy , schizophrenia , neuropathic pain , Raynaud 's disease , urticaria ) Acute medical condition would make study participation medically dangerous ( e.g. , acute hepatitis , unstable cardiovascular disease , liver disease , kidney disease ) Liver enzyme value five time great normal Currently take analgesic medication painful condition regular basis Current past history high blood pressure , heart disease , stroke Currently use pacemaker Pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>Opiate Addiction</keyword>
	<keyword>Opiate Dependence</keyword>
</DOC>